Nortech Systems Announces 2020 Results

MINNEAPOLIS--(BUSINESS WIRE)-- Nortech Systems Incorporated (Nasdaq: NSYS) (the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, aerospace & defense and industrial markets, reported net sales of $104.1 million for the year ended December 31, 2020, a decline of 10.5% compared to $116.3 for fiscal 2019. The decline was primarily due to reduced demand from medical and industrial customers impacted by COVID-19. Gross margin for fiscal 2020 was 8.1% compared to 10.8% in 2019, a decline of 2.7 percentage points. Gross margin in the fourth quarter was down approximately 6 percentage points versus the same period last year due to unabsorbed fixed overhead in the Company’s global manufacturing network. Net loss for fiscal year 2020 was ($1.5) million and ($0.58) per diluted share compared to a net loss of ($1.2) million and ($0.46) per diluted share in fiscal year 2019. Adjusted EBITDA was $0.1 million in fiscal 2020 compared to $2.4 million in fiscal 2019. The EBITDA decline was primarily due to reduced revenue in the fourth quarter related to COVID-19.

"The fourth quarter of 2020 was a significant challenge for Nortech due to the effects of COVID-19, related supply-chain challenges, and slower customer order volume. Our team battled through adversity, preserved our workforce with the help of a PPP loan, and continued supplying mission critical parts to our medical, industrial, and defense customers. Our monthly bookings trend improved late in the fourth quarter of 2020 and we are seeing those positive trends continue into the first quarter of 2021. The team has done a great job positioning the Company to return to profitable growth in 2021.” stated Jay D. Miller, Chief Executive Officer and President.

Revenue was $23.8 million for the fourth quarter ended December 31, 2020, compared with $30.8 million for the fourth quarter of 2019. Operating loss for the fourth quarter of 2020 was ($3.8) million which includes a $2.4 million non-cash charge due to the impairment of goodwill remaining from the acquisition of the Devicix business in 2015. During the fourth quarter of 2020 all aspects of Devicix engineering services were fully integrated into Nortech Systems to better facilitate our value proposition for providing innovative speed-to-market solutions for medical device customers. Excluding this one-time charge, adjusted operating loss for the fourth quarter of 2020 was ($1.4) million. This compares with operating income of $0.8 million for the fourth quarter of 2019. Net loss for the fourth quarter of 2020 was ($3.5) million, or ($1.33) per diluted common share compared with net income in the fourth quarter of 2019 of $0.3 million, or $0.10 per diluted common share. Adjusted EBITDA was a loss of ($0.9) million in the fourth quarter of 2020 compared to $1.4 million in fiscal 2019. The EBITDA decline was primarily due to reduced revenue related COVID-19. Nortech’s backlog at the end of the fourth quarter of 2020 was $48.7 million and is rebounding in the first quarter of 2021.

In the fourth quarter, Nortech’s Merrifield production facility consolidation was completed as planned. The Company shifted nearly all of its Printed Circuit Board (PCB) manufacturing to its Mankato, Minnesota production facility, and much of its complex wire and cable assembly production to its Bemidji, Minnesota production facility that recently achieved AS9100D certification.

Mr. Miller continued, “This consolidation reflects Nortech’s strategy of focusing our investments in talent, equipment, and infrastructure in fewer core ‘center of excellence’ locations to improve foundational capabilities that matter most to our customers: high quality, reliable on-time delivery, innovative solutions, and exceptional value. I am also excited about recent additions to our leadership team as we welcome Lianne King as our VP of Human Resources, Christine LaPoint as our Senior Director of Quality & Regulatory, and John Koski as the Plant Manager at our medical device center of excellence in Milaca, Minnesota. Lianne, Christine, and John all bring a wealth of experience to our leadership team. I’m thrilled to have them on board, and I am energized about the operational improvements they will implement in 2021 in conjunction with our entire global team."

Nortech, in partnership with our medical, industrial and defense customers, uses intelligence, innovation, speed and global expertise to provide manufacturing and engineering solutions. This enables our customers to be leaders in digital connectivity and data management to achieve their business goals. Nortech strives to be a premier workplace that fosters valued relationships internally and in our communities.

About Nortech Systems Incorporated Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech Systems primarily serves the medical, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire/cable/interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has seven manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.

Forward-Looking Statements This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 including without limitation statements regarding the Company returning to profitable growth, monthly booking trend, the effects of the Devicix integration, customer demand, the effects of the Merrifield plant consolidation, and the effects of changes in operations. While this release is based on management’s best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation: (1) the impact of the COVID-19 pandemic on our customers, employees, manufacturing facilities, suppliers, the capital markets and our financial condition, and results of operations, all of which tend to aggravate the other risks and uncertainties we face; (2) the impact of our indebtedness on our business, financial condition and results of operations; (3) the impact of restrictions in our debt instruments on our ability to operate our business, finance our capital needs or pursue or expand business strategies; (4) any failure to comply with financial covenants and other provisions and restrictions of our debt instruments; (5) supply chain disruptions leading to parts shortages for critical components; (6) volatility in market conditions which may affect market supply of and demand for the company’s products; (7) increased competition; (8) changes in the reliability and efficiency of operating facilities or those of third parties; (9) risks related to the availability of labor; (10) commodity cost increases coupled with our inability to raise prices charged to our customers; (11) the unanticipated loss of key members of senior management and the transition of new members of our management teams to their new roles; (12) and general economic, financial and business conditions that could affect the company’s financial condition and results of operations. Some of the above-mentioned factors are described in further detail in the section entitled “Risk Factors” in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial condition, results of operations and prospects may have changed since such date. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.

Non-GAAP Measurements Management believes that certain non-GAAP financial measures may be useful in providing additional meaningful comparisons between current results and results in prior periods. Adjusted EBITDA is a metric used by management to evaluate performance. Adjusted EBITDA is also used by the financial community to facilitate comparisons between peer companies since interest, taxes, depreciation, and amortization can differ greatly between organizations as a result of differing capital structures and tax strategies. Adjusted EBITDA excludes certain items that are unusual in nature or not comparable from period to period. The Company provides this information to investors to assist in comparisons of past, present, and future operating results and to assist in highlighting the results of on-going operations. While the Company’s management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace the Company’s GAAP financial results and should be read in conjunction with those GAAP results. Other supplemental information has been provided to demonstrate reconciliation of non-GAAP measurements discussed above to most relevant GAAP financial measurements.

Condensed Consolidated Statements of Operations

(in thousands, except for share data)

     
     

THREE MONTHS ENDED

 

 

TWELVE MONTHS ENDED

     

December 31,

 

 

December 31,

     

Unaudited

 

 

Unaudited

 

 

Audited

 

 

Audited

     

2020

 

 

2019

 

 

2020

 

 

2019

                         
Net Sales   $

23,843

  $

30,818

  $

104,106

  $

116,333

                         
Cost of Goods Sold    

22,480

   

27,163

   

95,651

   

103,757

                         
Gross Profit    

1,363

   

3,655

   

8,455

   

12,576

     

5.7%

   

11.9%

   

8.1%

   

10.8%

                         
Operating Expenses                        
Selling Expenses    

529

   

576

   

2,474

   

2,723

General and Administrative Expenses    

2,224

   

2,255

   

8,043

   

9,629

Loss on Impairment of Goodwill    

2,375

   

-

   

2,375

   

-

Gain on Sale of Property and Equipment    

-

   

-

   

(3,821)

   

-

Total Operating Expenses    

5,128

   

2,831

   

9,071

   

12,352

                         
Income (Loss) from Operations    

(3,765)

   

824

   

(616)

   

224

                         
Interest Expense    

(94)

   

(263)

   

(620)

   

(1,043)

                         
Income (Loss) Before Income Taxes    

(3,859)

   

561

   

(1,236)

   

(819)

                         
Income Tax (Benefit) Expense    

(328)

   

287

   

310

   

409

                         
Net Income (Loss)   $

(3,531)

  $

274

  $

(1,546)

  $

(1,228)

                         
Income (Loss) Per Common Share - Diluted   $

(1.33)

  $

0.10

  $

(0.58)

  $

(0.46)

                         
Weighted Average Number of Common Shares Outstanding - Diluted    

2,658,358

   

2,657,530

   

2,657,738

   

2,665,165

Condensed Consolidated Balance Sheets

(in thousands)

     

December 31,

 

 

December 31,

     

2020

 

 

2019

     

Audited

 

 

Audited

Cash   $

352

  $

351

Restricted Cash    

3,212

   

309

Accounts Receivable    

15,625

   

18,558

Inventories    

13,917

   

14,279

Contract Assets    

5,899

   

7,659

Prepaid Expenses and Other Current Assets    

2,032

   

2,128

Property and Operating Lease Assets    

15,424

   

14,408

Goodwill and Other Long-term Assets, Net    

1,173

   

3,718

Total Assets   $

57,634

  $

61,410

             
Accounts Payable   $

11,239

  $

14,014

Lease Obligations, Finance & Operating, Net    

11,389

   

7,232

All Other Liabilities    

5,891

   

6,477

Long Term Line of Credit    

3,328

   

10,088

Long-term Debt, Net    

7,069

   

3,623

Shareholders’ Equity    

18,718

   

19,976

Total Liabilities and Shareholders’ Equity   $

57,634

  $

61,410

Reconciliation of Net Income (Loss) to Adjusted EBITDA

(in thousands)

Adjusted EBITDA                        
     

THREE MONTHS ENDED

 

 

TWELVE MONTHS ENDED

     

December 31,

 

 

December 31,

     

2020

 

 

2019

 

 

2020

 

 

2019

Net Income (Loss)   $

(3,531)

  $

274

  $

(1,546)

  $

(1,228)

Income Tax (Benefit) Expense    

(328)

   

287

   

310

   

409

Interest Expense    

94

   

263

   

620

   

1,043

Depreciation and Amortization    

490

   

573

   

2,193

   

2,221

EBITDA    

(3,275)

   

1,397

   

1,577

   

2,445

Loss on goodwill impairment    

2,375

   

-

   

2,375

   

-

Gain on sale leaseback    

-

   

-

   

(3,821)

   

-

Adjusted EBITDA   $

(900)

  $

1,397

  $

131

  $

2,445

 

Contacts

Chris Jones, CFO
cjones@nortechsys.com
952-345-2244

 
 

Source: Nortech Systems Incorporated

Back to news